









Markets
/
Stocks
/
nasdaq-wrby
/

Warby Parker Inc

WRBY

28.480USD

+0.140+0.49%

Close 09/19, 16:00（ET）Quotes delayed by 15 min

3.47BMarket Cap

LossP/E TTM



Warby Parker Inc

28.480

+0.140+0.49%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated: 2025-09-19

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite a weak stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking

42 / 207

Overall Ranking

103 / 4720

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 15 analysts

Buy

Current Rating

26.083

Target Price

-7.96%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks

Warby Parker Inc. is a lifestyle brand that operates at the intersection of design, technology, healthcare, and social enterprise. It offers holistic vision care by selling eyewear products and providing optical services directly to consumers through its retail stores and e-commerce platform. It sells a range of prescription and non-prescription eyewear, including glasses, sunglasses, and contact lenses. Its customers can customize their prescription lenses with a variety of options, including single-vision, progressive, light-responsive, blue-light-filtering, and non-prescription lenses. It also offers in-house technologies like Virtual Vision Test and Virtual Try-On to enhance the overall customer experience. It sells its own brand of contacts, Scout by Warby Parker, and third-party contact lenses; this allows it to provide customers a vision care offering. Its Website and mobile app make it easy for its customers to browse, virtually try on, and purchase glasses.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 28.96% year-on-year.

Undervalued

The company’s latest PE is -372.92, at a low 3-year percentile range.

Institutional Selling

The latest institutional holdings are 106.87M shares, decreasing 4.21% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 10.32M shares of this stock.

Financial Health

Currency: USD Updated: 2025-09-19

The company's current financial score is 7.56, which is higher than the Healthcare Equipment & Supplies industry's average of 7.32. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 214.47M, representing a year-over-year increase of 13.95%, while its net profit experienced a year-over-year increase of 74.09%.

Score

Industry at a Glance

Previous score

7.56

Change



Financials

9.58

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

2.57

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

9.24

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

8.98

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.42

Key Metrics

Free cash flow

No Data

Company Valuation

Currency: USD Updated: 2025-09-19

The company’s current valuation score is 2.80, which is lower than the Healthcare Equipment & Supplies industry's average of 3.59. Its current P/E ratio is -371.09, which is -94.63% below the recent high of -19.94 and 83.07% above the recent low of -62.82.

Score

Industry at a Glance

Previous score

2.80

Change

1.2

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 42/207

No Data

Earnings Forecast

Currency: USD Updated: 2025-09-19

The company’s current earnings forecast score is 7.47, which is lower than the Healthcare Equipment & Supplies industry's average of 7.70. The average price target for Warby Parker Inc is 27.50, with a high of 30.00 and a low of 20.00.

Score

Industry at a Glance

Previous score

7.47

Change

Support & Resistance

No Data

Analyst Rating

Based on 15 analysts

Buy

Current Rating

26.083

Target Price

-7.96%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

118

Total

Median

Average

Company name

Ratings

Analysts

Warby Parker Inc

WRBY

Medtronic PLC

MDT

Stryker Corp

SYK

Abbott Laboratories

ABT

Zimmer Biomet Holdings Inc

ZBH

Dexcom Inc

DXCM

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-09-19

The company’s current price momentum score is 9.07, which is higher than the Healthcare Equipment & Supplies industry's average of 6.80. Sideways: Currently, the stock price is trading between the resistance level at 29.49 and the support level at 26.09, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

9.07

Change

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(1)

Neutral(1)

Buy(3)

Indicators

Value

Direction

MACD(12,26,9)

0.199

Buy

RSI(14)

65.416

Neutral

STOCH(KDJ)(9,3,3)

88.935

Overbought

ATR(14)

0.884

High Vlolatility

CCI(14)

163.357

Buy

Williams %R

3.308

Overbought

TRIX(12,20)

0.304

Sell

StochRSI(14)

100.000

Buy

Moving Average

Sell(0)

Neutral(0)

Buy(6)

Indicators

Value

Direction

MA5

27.414

Buy

MA10

27.209

Buy

MA20

26.655

Buy

MA50

25.346

Buy

MA100

22.742

Buy

MA200

22.515

Buy

Institutional Confidence

Currency: USD Updated: 2025-09-19

The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Equipment & Supplies industry's average of 6.89. The latest institutional shareholding proportion is 102.25%, representing a quarter-over-quarter increase of 1.50%. The largest institutional shareholder is The Vanguard, holding a total of 10.32M shares, representing 9.81% of shares outstanding, with 3.00% increase in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

The Vanguard Group, Inc.

Star Investors

9.68M

-1.21%

Durable Capital Partners LP

10.21M

+13.25%

BlackRock Institutional Trust Company, N.A.

6.55M

-2.25%

Fidelity Management & Research Company LLC

2.66M

-53.82%

Raider (Jeffrey Jacob)

4.20M

+0.29%

Macquarie Investment Management

2.16M

+22.79%

Geode Capital Management, L.L.C.

2.05M

+2.77%

Risk Assessment

Currency: USD Updated: 2025-09-19

The company’s current risk assessment score is 3.24, which is lower than the Healthcare Equipment & Supplies industry's average of 3.87. The company's beta value is 2.11. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.